Pharma News

The U.S. Food and Drug Administration has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial drug product to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).

Tuberculosis infection results in approximately nine million new cases worldwide every year. TB - causing bacterium can remain dormant in human body for a long time, even for several decades before it becomes infectious. The bacterium remains ensconced within a type of white blood cells called macrophages, when it is in its latent form.

Diabetes - increase in blood glucose levels - is an emerging health problem especially in developing countries. According to the World Health Organisation, India had 69 million diabetic individuals in 2015 and the number is projected to go up to 98 million by 2030. The problem is more serious for Asians as their genetic makeup puts them at a greater risk of diabetes at a younger age than their European counterparts.

Packaging is no longer a reference to a box or a carton, but rather to a coordinated system of preparing goods for safe, cost-effective, and efficient movement throughout the whole supply chain that eventually leads to maximizing consumer value, sales, and hence profits. The ever-evolving global pharmaceutical packaging industry holds a market size of around $95 - $97 billion. This market is expected to witness a notable growth with a healthy CAGR of 6% to 7% in the coming years, owing to the increased R&D, new innovations in packaging materials, growth in generic market & rise in the trend of contract packaging. The brand matters and the companies need to protect it. They have worked hard to build the customers trust and loyalty. This industry is in a constant battle against counterfeiting & is thriving hard towards its Brand Protection.

EMA’s safety committee (PRAC) is recommending new measures to avoid dosing errors that have led to some patients incorrectly taking methotrexate-containing medicines daily instead of weekly.

With the recognition by the US Food and Drug Administration (FDA)of Slovakia, the European Union and the United States have now fully implemented the mutual recognition agreement (MRA) for inspections of manufacturing sites for certain human medicines in their respective territories.

Medicated stents are widely used to unblock heart arteries. While the drug prevents the growth of muscle cells around the stent, it however, retards endothelial cells necessary for healing the wound site and may result in the formation of clots. That’s why anti-clotting medications are given, which must be taken life-long; also, they come with adverse side effects.

The European Union task force set up to address problems with medicines supply has published two documents today: guidance for marketing authorisation holders on reporting of shortages in the EU good practice and  guidance for communication to the public on medicines’ availability issues.